Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Plantar Fasciosis Treatment Using Coblation

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Linkul este salvat în clipboard
stareEfectuat
Sponsorii
ArthroCare Corporation

Cuvinte cheie

Abstract

The purpose of this study is to evaluate the effectiveness of Coblation-based fasciotomy for relieving pain associated with recurring plantar fasciosis and, secondarily, to determine whether there may be additional potential benefits stemming from its use.

Descriere

Severe recalcitrant heel pain, resulting from repetitive trauma to the plantar fascia, is a relatively commonly observed phenomenon. Although this condition is frequently referred to as 'heel spurs', plantar fasciitis (acute inflammatory stage) and plantar fasciosis (chronic degeneration) are currently accepted as the more accurate terms. Symptoms most often occur during the first few steps in the morning but may also be effected during intense activity or with prolonged standing. The source of pain symptoms, which are usually perceived as a gradual onset of burning, is located at the origin of the plantar fascia at the calcaneous (heel bone). Risk factors such as low or high arches or over-pronation of the foot, systemic disease, or obesity may exacerbate pain.

More than two million Americans receive treatment each year for plantar fasciitis and fasciosis. Conservative treatment options for plantar fasciosis include rest, stretching, strengthening, and massage, progressing to non-steroidal anti-inflammatories, steroid injections or iontophoresis with continued recalcitrance. Orthotics, heel cups, night splints and plantar strapping are other conservative options frequently recommended by treating physicians. Patient outcomes and response to conservative measures are usually positive, with non-responsive cases, approximately 10% of all presenting cases, receiving surgical care. Extracorporeal shockwave treatment has recently been advocated for the recalcitrant cases and has shown to be effective in 60-80 percent of the cases. Plantar fascia release, either partial or complete, is commonly the surgical procedure of choice for treating plantar fasciosis. However, this surgery has a risk of complications and is thought to alter the biomechanics of the foot, which may be linked to post-operative lateral column pain and long-term disability. Because of the potential postoperative sequelae with plantar fascia release, it is valuable to examine less invasive surgical techniques for treating recalcitrant plantar fasciosis.

The concept of using a plasma RF-based microsurgical approach as a viable modality for treating tendinosis, and now, recalcitrant plantar fasciosis, was originally drawn from the research work conducted in patients treated for congestive heart failure using laser or RF-based transmyocardial revascularization (TMR). The mechanism of action behind the clinical success observed with laser and RF-based TMR was theorized to be associated with the localized angiogenic healing response noted to occur following the procedure. Localized angiogenesis had not been observed previously using mechanical devices for TMR, which were also less successful clinically. To substantiate adopting a TMR-like approach for treating tendinosis, the capability of plasma RF-based microsurgery for initiating an angiogenic healing response was examined in vivo using histology and biochemical analysis. The sum of several studies provides good evidence to suggest that plasma RF-based microsurgery can promote an angiogenic healing response using an appropriate application.

Preliminary clinical experience following plasma RF-based micro-tenotomy has demonstrated excellent success in treating chronic, refractive tendinosis. The investigators reported that this technique was technically simple to perform and was much less invasive than conventional surgery. Patients had a rapid and uncomplicated recovery and reported minimal to no pain 7-10 days following the procedure; their pain relief persisted or improved through 24 months. Magnetic resonance imaging correlated well with clinical results. These promising clinical findings, as well as the evidence from the basic research studies, led us to consider evaluating this plasma RF-based approach for treating symptomatic, chronic, recalcitrant heel pain resembling plantar fasciosis. The purpose of this study is to evaluate the effectiveness of Coblation-based fasciotomy for relieving pain associated with recalcitrant plantar fasciosis and, secondarily, to determine whether there may be additional potential benefits stemming from its use, such as reduced incidence of postoperative complications and improved function, compared to conventional surgery.

Datele

Ultima verificare: 07/31/2015
Primul depus: 09/11/2005
Inscriere estimată trimisă: 09/11/2005
Prima postare: 09/18/2005
Ultima actualizare trimisă: 08/24/2015
Ultima actualizare postată: 08/25/2015
Data actuală de începere a studiului: 07/31/2005
Data estimată de finalizare primară: 05/31/2008
Data estimată de finalizare a studiului: 05/31/2008

Stare sau boală

Plantar Fasciitis

Intervenție / tratament

Device: A

Procedure: 2

Fază

Fază 4

Grupuri de brațe

BraţIntervenție / tratament
Experimental: A
Percutaneous Fasciotomy
Device: A
Percutaneous treatment of plantar fascia using the Topaz device. No incision performed.
Active Comparator: 2
Standard Fasciotomy
Procedure: 2
Standard surgical fasciotomy using an incision to treat the plantar fascia.

Criterii de eligibilitate

Vârste eligibile pentru studiu 18 Years La 18 Years
Sexe eligibile pentru studiuAll
Acceptă voluntari sănătoșida
Criterii

Inclusion Criteria:

- Diagnosis of plantar fasciitis/fasciosis by all of the following:

- Tenderness with palpation and local pressure over the medial calcaneal tuberosity on passive dorsiflexion of the foot

- VAS (Visual Analog Scale) pain score of > 5 points on a scale of 0 to 10, during the first few minutes of walking in the morning

- Ultrasound or magnetic resonance imaging (MRI) confirming plantar fasciitis/fasciosis

- Symptoms consistent with plantar fasciitis/fasciosis for at least 6 months as assessed by patient history

- Pain unresponsive to non-steroidal anti-inflammatory drugs (NSAIDs) and any four of the following conservative treatments: rest, taping, orthotics, shoe modifications, night splinting, casting, physical therapy, or local corticosteroid injections for up to 3 months

- Must be at least 18 years old and no more than 72 years old

- Must sign the Institutional Review Board (IRB) approved informed consent form

- Subject is willing and able to complete required follow-up

Exclusion Criteria:

- Body mass index (BMI) > 40

- History or documentation showing type I and type II diabetes mellitus

- Physical findings and documentation of coagulopathy, infection, tumor or other systemic disease(s)

- History or documentation showing peripheral vascular disease or autoimmune disease

- Subject has received NSAIDs (e.g., ibuprofen, naproxen) for treatment of plantar fasciitis/fasciosis 2 weeks prior to treatment by this study

- Subject has received NSAIDs (e.g. ibuprofen, naproxen) or oral corticosteroids 2 weeks prior to treatment by this study

- Subject is receiving worker's compensation

- Subject is currently involved in litigation related to the injury being studied

- Prior surgical treatment of the plantar fascia(s) to be treated by this study

- Subject is currently participating in another drug/device study related to the injured plantar fascia

- Pregnant or pregnant suspected subjects

- Clinically significant bilateral plantar fasciitis/fasciosis with a VAS pain scale of > 5 bilaterally

- Subject is not capable of understanding or responding to study questionnaires.

- Extracorporeal shockwave therapy (ESWT) within 6 months of study treatment

Rezultat

Măsuri de rezultate primare

1. Pain relief [at 24 hours, 48 hours, 7 to 14 days, 4 to 6 weeks, 3 months, 6 months, 12 months]

Măsuri de rezultate secundare

1. Compare the number of postoperative complications [When and if they occur]

2. Evaluate changes in biomechanical function using Ankle-Hindfoot and Midfoot Scale [4 to 6 weeks, 3 months, 6 months and 1 year]

3. Assess function and quality of life by the sf-36 questionnaire [at 4 to 6 weeks, 3 months, 6 months, 1 year]

Alăturați-vă paginii
noastre de facebook

Cea mai completă bază de date cu plante medicinale susținută de știință

  • Funcționează în 55 de limbi
  • Cure pe bază de plante susținute de știință
  • Recunoașterea ierburilor după imagine
  • Harta GPS interactivă - etichetați ierburile în locație (în curând)
  • Citiți publicațiile științifice legate de căutarea dvs.
  • Căutați plante medicinale după efectele lor
  • Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate

Google Play badgeApp Store badge